Market Closed -
Japan Exchange
11:30:00 26/04/2024 am IST
|
5-day change
|
1st Jan Change
|
639
JPY
|
-2.59%
|
|
-1.54%
|
-3.18%
|
Fiscal Period: May |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
6,156
|
4,740
|
6,164
|
7,211
|
6,809
|
5,759
|
Enterprise Value (EV)
1 |
13,053
|
11,475
|
12,921
|
13,304
|
12,730
|
10,155
|
P/E ratio
|
-220
x
|
229
x
|
14.3
x
|
22.4
x
|
20.1
x
|
22.7
x
|
Yield
|
2.06%
|
2.73%
|
2.11%
|
1.81%
|
1.92%
|
2.29%
|
Capitalization / Revenue
|
0.11
x
|
0.09
x
|
0.12
x
|
0.14
x
|
0.13
x
|
0.11
x
|
EV / Revenue
|
0.24
x
|
0.22
x
|
0.25
x
|
0.25
x
|
0.25
x
|
0.2
x
|
EV / EBITDA
|
5.21
x
|
6.16
x
|
5.71
x
|
5.13
x
|
4.5
x
|
3.81
x
|
EV / FCF
|
11.5
x
|
18.4
x
|
12.7
x
|
9.37
x
|
57.6
x
|
5.14
x
|
FCF Yield
|
8.67%
|
5.43%
|
7.9%
|
10.7%
|
1.74%
|
19.4%
|
Price to Book
|
1.13
x
|
0.87
x
|
1.04
x
|
1.16
x
|
1.03
x
|
0.84
x
|
Nbr of stocks (in thousands)
|
9,039
|
9,240
|
9,298
|
9,305
|
9,353
|
9,426
|
Reference price
2 |
681.0
|
513.0
|
663.0
|
775.0
|
728.0
|
611.0
|
Announcement Date
|
29/08/18
|
29/08/19
|
27/08/20
|
27/08/21
|
26/08/22
|
31/08/23
|
Fiscal Period: May |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
54,562
|
51,728
|
51,030
|
52,324
|
51,608
|
52,030
|
EBITDA
1 |
2,507
|
1,863
|
2,264
|
2,591
|
2,829
|
2,663
|
EBIT
1 |
1,181
|
640
|
1,036
|
1,247
|
1,521
|
1,439
|
Operating Margin
|
2.16%
|
1.24%
|
2.03%
|
2.38%
|
2.95%
|
2.77%
|
Earnings before Tax (EBT)
1 |
415
|
400
|
818
|
1,202
|
1,321
|
1,049
|
Net income
1 |
-28
|
23
|
577
|
426
|
447
|
333
|
Net margin
|
-0.05%
|
0.04%
|
1.13%
|
0.81%
|
0.87%
|
0.64%
|
EPS
2 |
-3.098
|
2.240
|
46.32
|
34.59
|
36.22
|
26.86
|
Free Cash Flow
1 |
1,132
|
622.8
|
1,020
|
1,420
|
221
|
1,975
|
FCF margin
|
2.07%
|
1.2%
|
2%
|
2.71%
|
0.43%
|
3.8%
|
FCF Conversion (EBITDA)
|
45.15%
|
33.43%
|
45.06%
|
54.79%
|
7.81%
|
74.16%
|
FCF Conversion (Net income)
|
-
|
2,707.61%
|
176.82%
|
333.22%
|
49.44%
|
593.09%
|
Dividend per Share
2 |
14.00
|
14.00
|
14.00
|
14.00
|
14.00
|
14.00
|
Announcement Date
|
29/08/18
|
29/08/19
|
27/08/20
|
27/08/21
|
26/08/22
|
31/08/23
|
Fiscal Period: May |
2020 S1
|
2021 S1
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 S1
|
2023 Q3
|
2024 Q1
|
2024 S1
|
2024 Q3
|
---|
Net sales
1 |
-
|
25,666
|
25,903
|
12,676
|
12,861
|
25,745
|
12,985
|
13,471
|
26,948
|
13,726
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
525
|
788
|
212
|
348
|
573
|
323
|
331
|
710
|
153
|
Operating Margin
|
-
|
2.05%
|
3.04%
|
1.67%
|
2.71%
|
2.23%
|
2.49%
|
2.46%
|
2.63%
|
1.11%
|
Earnings before Tax (EBT)
1 |
-
|
471
|
775
|
192
|
318
|
394
|
328
|
312
|
662
|
99
|
Net income
1 |
-
|
127
|
250
|
72
|
111
|
72
|
136
|
123
|
273
|
-96
|
Net margin
|
-
|
0.49%
|
0.97%
|
0.57%
|
0.86%
|
0.28%
|
1.05%
|
0.91%
|
1.01%
|
-0.7%
|
EPS
2 |
-
|
13.73
|
26.94
|
7.660
|
11.88
|
7.760
|
14.48
|
13.11
|
28.29
|
-11.07
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
-
|
14/01/21
|
13/01/22
|
12/04/22
|
13/10/22
|
29/12/22
|
30/03/23
|
02/10/23
|
25/12/23
|
25/03/24
|
Fiscal Period: May |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
6,897
|
6,735
|
6,757
|
6,093
|
5,921
|
4,396
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.751
x
|
3.615
x
|
2.985
x
|
2.352
x
|
2.093
x
|
1.651
x
|
Free Cash Flow
1 |
1,132
|
623
|
1,020
|
1,420
|
221
|
1,975
|
ROE (net income / shareholders' equity)
|
-3.59%
|
-0.18%
|
10%
|
6.84%
|
7.02%
|
5.07%
|
ROA (Net income/ Total Assets)
|
3.02%
|
1.65%
|
2.62%
|
3.12%
|
3.92%
|
3.81%
|
Assets
1 |
-925.7
|
1,394
|
22,021
|
13,646
|
11,396
|
8,732
|
Book Value Per Share
2 |
601.0
|
591.0
|
636.0
|
669.0
|
706.0
|
730.0
|
Cash Flow per Share
2 |
404.0
|
477.0
|
481.0
|
495.0
|
427.0
|
503.0
|
Capex
1 |
403
|
400
|
349
|
508
|
379
|
380
|
Capex / Sales
|
0.74%
|
0.77%
|
0.68%
|
0.97%
|
0.73%
|
0.73%
|
Announcement Date
|
29/08/18
|
29/08/19
|
27/08/20
|
27/08/21
|
26/08/22
|
31/08/23
|
|
1st Jan change
|
Capi.
|
---|
| -3.18% | 45.64M | | -12.86% | 8.57B | | +32.95% | 1.32B | | +6.76% | 419M | | +5.93% | 282M | | +10.56% | 224M | | -8.26% | 85.07M | | +20.94% | 59.57M |
Retail - Drugs without Grocery
|